Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. (2024)
Attributed to:
MICA: MRC APBI STratification and Extreme Response Mechanism IN Diabetes - MASTERMIND
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00125-024-06099-3
PubMed Identifier: 38388753
Publication URI: http://europepmc.org/abstract/MED/38388753
Type: Journal Article/Review
Volume: 67
Parent Publication: Diabetologia
Issue: 5
ISSN: 0012-186X